Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): a pilot study
Objective: To define the effects of Lee Silverman Voice Treatment (LSVT® on swallowing and voice in eight patients with idiopathic Parkinson's disease. Methods: Each patient received a modified barium swallow (MBS) in addition to voice recording before and after 1 month of LSVT®. Swallowing mot...
Gespeichert in:
| Veröffentlicht in: | Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 2002-01, Vol.72 (1), p.31-36 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 36 |
|---|---|
| container_issue | 1 |
| container_start_page | 31 |
| container_title | Journal of neurology, neurosurgery and psychiatry |
| container_volume | 72 |
| creator | El Sharkawi, A Ramig, L Logemann, J A Pauloski, B R Rademaker, A W Smith, C H Pawlas, A Baum, S Werner, C |
| description | Objective: To define the effects of Lee Silverman Voice Treatment (LSVT® on swallowing and voice in eight patients with idiopathic Parkinson's disease. Methods: Each patient received a modified barium swallow (MBS) in addition to voice recording before and after 1 month of LSVT®. Swallowing motility disorders were defined and temporal measures of the swallow were completed from the MBS. Voice evaluation included measures of vocal intensity, fundamental frequency, and the patient's perception of speech change. Results: before LSVT®, the most prevalent swallowing motility disorders were oral phase problems including reduced tongue control and strength. Reduced tongue base retraction resulting in residue in the vallecula was the most common disorder in the pharyngeal stage of the swallow. Oral transit time (OTT) and pharyngeal transit time (PTT) were prolonged. After LSVT®, there was an overall 51% reduction in the number of swallowing motility disorders. Some temporal measures of swallowing were also significantly reduced as was the approximate amount of oral residue after 3 ml and 5 ml liquid swallows. Voice changes after LSVT® included a significant increase in vocal intensity during sustained vowel phonation as well as during reading. Conclusions: LSVT® seemingly improved neuromuscular control of the entire upper aerodigestive tract, improving oral tongue and tongue base function during the oral and pharyngeal phases of swallowing as well as improving vocal intensity. |
| doi_str_mv | 10.1136/jnnp.72.1.31 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1737706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71358045</sourcerecordid><originalsourceid>FETCH-LOGICAL-b574t-94bd9a0d1f9da0e1f447671930b6b4fbd382454033f0b090c24dbb264174814c3</originalsourceid><addsrcrecordid>eNp90c1uEzEUBWALgWgo7FgjS4g_iQm-Y8_Yw6ISiqAgorJIGhAbyzNjF6czdmpPUvpSPARPhkOiFljgjRf309G5ugg9BDIGoOWrpXOrMc_HMKZwC42AlSKjlHy5jUaE5HlGSUEO0L0Yl2T7RHUXHQBwwUQOI3Q6u1Rd5y-tO8PKtXjjbaOxNkY3Q8Te4KnWeGa7jQ69cnjxezwPWg29dgN-Pp0t5j9_vHiNFV7Zzg84Duv26j66Y1QX9YP9f4hO372dT95n00_HHyZvplldcDZkFavbSpEWTNUqosEwxksOFSV1WTNTt1TkrGCEUkNqUpEmZ21d5yUDzgSwhh6io13ual33um1SpaA6uQq2V-FKemXl3xNnv8kzv5HAKeekTAFP9wHBX6x1HGRvY6O7Tjnt11FyoIUgrEjw8T9w6dfBpeVSloACREWrpF7uVBN8jEGb6ypA5PZacnstyXMJkkLij_6sf4P350ngyR6o2KjOBOUaG28cpaJkFUsu2zkbB_39eq7CuSzTpoU8WUzkyfFHmn-dFfJz8s92vu6X_6_4CycluTE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781518939</pqid></control><display><type>article</type><title>Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): a pilot study</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>El Sharkawi, A ; Ramig, L ; Logemann, J A ; Pauloski, B R ; Rademaker, A W ; Smith, C H ; Pawlas, A ; Baum, S ; Werner, C</creator><creatorcontrib>El Sharkawi, A ; Ramig, L ; Logemann, J A ; Pauloski, B R ; Rademaker, A W ; Smith, C H ; Pawlas, A ; Baum, S ; Werner, C</creatorcontrib><description>Objective: To define the effects of Lee Silverman Voice Treatment (LSVT® on swallowing and voice in eight patients with idiopathic Parkinson's disease. Methods: Each patient received a modified barium swallow (MBS) in addition to voice recording before and after 1 month of LSVT®. Swallowing motility disorders were defined and temporal measures of the swallow were completed from the MBS. Voice evaluation included measures of vocal intensity, fundamental frequency, and the patient's perception of speech change. Results: before LSVT®, the most prevalent swallowing motility disorders were oral phase problems including reduced tongue control and strength. Reduced tongue base retraction resulting in residue in the vallecula was the most common disorder in the pharyngeal stage of the swallow. Oral transit time (OTT) and pharyngeal transit time (PTT) were prolonged. After LSVT®, there was an overall 51% reduction in the number of swallowing motility disorders. Some temporal measures of swallowing were also significantly reduced as was the approximate amount of oral residue after 3 ml and 5 ml liquid swallows. Voice changes after LSVT® included a significant increase in vocal intensity during sustained vowel phonation as well as during reading. Conclusions: LSVT® seemingly improved neuromuscular control of the entire upper aerodigestive tract, improving oral tongue and tongue base function during the oral and pharyngeal phases of swallowing as well as improving vocal intensity.</description><identifier>ISSN: 0022-3050</identifier><identifier>EISSN: 1468-330X</identifier><identifier>DOI: 10.1136/jnnp.72.1.31</identifier><identifier>PMID: 11784821</identifier><identifier>CODEN: JNNPAU</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd</publisher><subject>Aged ; ASPB ; ASPD ; aspiration before the swallow ; aspiration during the swallow ; Barium ; Biological and medical sciences ; cricopharyngeal ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Deglutition - physiology ; dysphagia ; Female ; Follow-Up Studies ; Functional investigation of the digestive system ; fundamental frequency ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Lee Silverman Voice Treatment Program ; LSVT ; Male ; MBS ; Medical sciences ; Middle Aged ; modified barium swallow ; Motility ; Neurology ; OPSE ; oral transit time ; ORES ; oropharyngeal swallow efficiency ; OTT ; Parkinson Disease - physiopathology ; Parkinson Disease - therapy ; Parkinson's disease ; Patients ; percentage of oral residue ; percentage of pharyngeal residue ; pharyngeal transit time ; Phonetics ; Pilot projects ; PRES ; PRT ; PTT ; Self evaluation ; sound pressure level ; Sound Spectrography ; Speech Therapy ; SPL ; Swallowing ; Treatment Outcome ; Video recorders ; Voice Disorders - physiopathology ; Voice Disorders - therapy ; Voice Quality - physiology ; Voice Training</subject><ispartof>Journal of neurology, neurosurgery and psychiatry, 2002-01, Vol.72 (1), p.31-36</ispartof><rights>Copyright 2002 Journal of Neurology Neurosurgery and Psychiatry</rights><rights>2002 INIST-CNRS</rights><rights>Copyright: 2002 Copyright 2002 Journal of Neurology Neurosurgery and Psychiatry</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b574t-94bd9a0d1f9da0e1f447671930b6b4fbd382454033f0b090c24dbb264174814c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1737706/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1737706/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,729,782,786,887,4026,27930,27931,27932,53798,53800</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13386494$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11784821$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>El Sharkawi, A</creatorcontrib><creatorcontrib>Ramig, L</creatorcontrib><creatorcontrib>Logemann, J A</creatorcontrib><creatorcontrib>Pauloski, B R</creatorcontrib><creatorcontrib>Rademaker, A W</creatorcontrib><creatorcontrib>Smith, C H</creatorcontrib><creatorcontrib>Pawlas, A</creatorcontrib><creatorcontrib>Baum, S</creatorcontrib><creatorcontrib>Werner, C</creatorcontrib><title>Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): a pilot study</title><title>Journal of neurology, neurosurgery and psychiatry</title><addtitle>J Neurol Neurosurg Psychiatry</addtitle><description>Objective: To define the effects of Lee Silverman Voice Treatment (LSVT® on swallowing and voice in eight patients with idiopathic Parkinson's disease. Methods: Each patient received a modified barium swallow (MBS) in addition to voice recording before and after 1 month of LSVT®. Swallowing motility disorders were defined and temporal measures of the swallow were completed from the MBS. Voice evaluation included measures of vocal intensity, fundamental frequency, and the patient's perception of speech change. Results: before LSVT®, the most prevalent swallowing motility disorders were oral phase problems including reduced tongue control and strength. Reduced tongue base retraction resulting in residue in the vallecula was the most common disorder in the pharyngeal stage of the swallow. Oral transit time (OTT) and pharyngeal transit time (PTT) were prolonged. After LSVT®, there was an overall 51% reduction in the number of swallowing motility disorders. Some temporal measures of swallowing were also significantly reduced as was the approximate amount of oral residue after 3 ml and 5 ml liquid swallows. Voice changes after LSVT® included a significant increase in vocal intensity during sustained vowel phonation as well as during reading. Conclusions: LSVT® seemingly improved neuromuscular control of the entire upper aerodigestive tract, improving oral tongue and tongue base function during the oral and pharyngeal phases of swallowing as well as improving vocal intensity.</description><subject>Aged</subject><subject>ASPB</subject><subject>ASPD</subject><subject>aspiration before the swallow</subject><subject>aspiration during the swallow</subject><subject>Barium</subject><subject>Biological and medical sciences</subject><subject>cricopharyngeal</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Deglutition - physiology</subject><subject>dysphagia</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Functional investigation of the digestive system</subject><subject>fundamental frequency</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Lee Silverman Voice Treatment Program</subject><subject>LSVT</subject><subject>Male</subject><subject>MBS</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>modified barium swallow</subject><subject>Motility</subject><subject>Neurology</subject><subject>OPSE</subject><subject>oral transit time</subject><subject>ORES</subject><subject>oropharyngeal swallow efficiency</subject><subject>OTT</subject><subject>Parkinson Disease - physiopathology</subject><subject>Parkinson Disease - therapy</subject><subject>Parkinson's disease</subject><subject>Patients</subject><subject>percentage of oral residue</subject><subject>percentage of pharyngeal residue</subject><subject>pharyngeal transit time</subject><subject>Phonetics</subject><subject>Pilot projects</subject><subject>PRES</subject><subject>PRT</subject><subject>PTT</subject><subject>Self evaluation</subject><subject>sound pressure level</subject><subject>Sound Spectrography</subject><subject>Speech Therapy</subject><subject>SPL</subject><subject>Swallowing</subject><subject>Treatment Outcome</subject><subject>Video recorders</subject><subject>Voice Disorders - physiopathology</subject><subject>Voice Disorders - therapy</subject><subject>Voice Quality - physiology</subject><subject>Voice Training</subject><issn>0022-3050</issn><issn>1468-330X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp90c1uEzEUBWALgWgo7FgjS4g_iQm-Y8_Yw6ISiqAgorJIGhAbyzNjF6czdmpPUvpSPARPhkOiFljgjRf309G5ugg9BDIGoOWrpXOrMc_HMKZwC42AlSKjlHy5jUaE5HlGSUEO0L0Yl2T7RHUXHQBwwUQOI3Q6u1Rd5y-tO8PKtXjjbaOxNkY3Q8Te4KnWeGa7jQ69cnjxezwPWg29dgN-Pp0t5j9_vHiNFV7Zzg84Duv26j66Y1QX9YP9f4hO372dT95n00_HHyZvplldcDZkFavbSpEWTNUqosEwxksOFSV1WTNTt1TkrGCEUkNqUpEmZ21d5yUDzgSwhh6io13ual33um1SpaA6uQq2V-FKemXl3xNnv8kzv5HAKeekTAFP9wHBX6x1HGRvY6O7Tjnt11FyoIUgrEjw8T9w6dfBpeVSloACREWrpF7uVBN8jEGb6ypA5PZacnstyXMJkkLij_6sf4P350ngyR6o2KjOBOUaG28cpaJkFUsu2zkbB_39eq7CuSzTpoU8WUzkyfFHmn-dFfJz8s92vu6X_6_4CycluTE</recordid><startdate>200201</startdate><enddate>200201</enddate><creator>El Sharkawi, A</creator><creator>Ramig, L</creator><creator>Logemann, J A</creator><creator>Pauloski, B R</creator><creator>Rademaker, A W</creator><creator>Smith, C H</creator><creator>Pawlas, A</creator><creator>Baum, S</creator><creator>Werner, C</creator><general>BMJ Publishing Group Ltd</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200201</creationdate><title>Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): a pilot study</title><author>El Sharkawi, A ; Ramig, L ; Logemann, J A ; Pauloski, B R ; Rademaker, A W ; Smith, C H ; Pawlas, A ; Baum, S ; Werner, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b574t-94bd9a0d1f9da0e1f447671930b6b4fbd382454033f0b090c24dbb264174814c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Aged</topic><topic>ASPB</topic><topic>ASPD</topic><topic>aspiration before the swallow</topic><topic>aspiration during the swallow</topic><topic>Barium</topic><topic>Biological and medical sciences</topic><topic>cricopharyngeal</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Deglutition - physiology</topic><topic>dysphagia</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Functional investigation of the digestive system</topic><topic>fundamental frequency</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Lee Silverman Voice Treatment Program</topic><topic>LSVT</topic><topic>Male</topic><topic>MBS</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>modified barium swallow</topic><topic>Motility</topic><topic>Neurology</topic><topic>OPSE</topic><topic>oral transit time</topic><topic>ORES</topic><topic>oropharyngeal swallow efficiency</topic><topic>OTT</topic><topic>Parkinson Disease - physiopathology</topic><topic>Parkinson Disease - therapy</topic><topic>Parkinson's disease</topic><topic>Patients</topic><topic>percentage of oral residue</topic><topic>percentage of pharyngeal residue</topic><topic>pharyngeal transit time</topic><topic>Phonetics</topic><topic>Pilot projects</topic><topic>PRES</topic><topic>PRT</topic><topic>PTT</topic><topic>Self evaluation</topic><topic>sound pressure level</topic><topic>Sound Spectrography</topic><topic>Speech Therapy</topic><topic>SPL</topic><topic>Swallowing</topic><topic>Treatment Outcome</topic><topic>Video recorders</topic><topic>Voice Disorders - physiopathology</topic><topic>Voice Disorders - therapy</topic><topic>Voice Quality - physiology</topic><topic>Voice Training</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>El Sharkawi, A</creatorcontrib><creatorcontrib>Ramig, L</creatorcontrib><creatorcontrib>Logemann, J A</creatorcontrib><creatorcontrib>Pauloski, B R</creatorcontrib><creatorcontrib>Rademaker, A W</creatorcontrib><creatorcontrib>Smith, C H</creatorcontrib><creatorcontrib>Pawlas, A</creatorcontrib><creatorcontrib>Baum, S</creatorcontrib><creatorcontrib>Werner, C</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neurology, neurosurgery and psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>El Sharkawi, A</au><au>Ramig, L</au><au>Logemann, J A</au><au>Pauloski, B R</au><au>Rademaker, A W</au><au>Smith, C H</au><au>Pawlas, A</au><au>Baum, S</au><au>Werner, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): a pilot study</atitle><jtitle>Journal of neurology, neurosurgery and psychiatry</jtitle><addtitle>J Neurol Neurosurg Psychiatry</addtitle><date>2002-01</date><risdate>2002</risdate><volume>72</volume><issue>1</issue><spage>31</spage><epage>36</epage><pages>31-36</pages><issn>0022-3050</issn><eissn>1468-330X</eissn><coden>JNNPAU</coden><abstract>Objective: To define the effects of Lee Silverman Voice Treatment (LSVT® on swallowing and voice in eight patients with idiopathic Parkinson's disease. Methods: Each patient received a modified barium swallow (MBS) in addition to voice recording before and after 1 month of LSVT®. Swallowing motility disorders were defined and temporal measures of the swallow were completed from the MBS. Voice evaluation included measures of vocal intensity, fundamental frequency, and the patient's perception of speech change. Results: before LSVT®, the most prevalent swallowing motility disorders were oral phase problems including reduced tongue control and strength. Reduced tongue base retraction resulting in residue in the vallecula was the most common disorder in the pharyngeal stage of the swallow. Oral transit time (OTT) and pharyngeal transit time (PTT) were prolonged. After LSVT®, there was an overall 51% reduction in the number of swallowing motility disorders. Some temporal measures of swallowing were also significantly reduced as was the approximate amount of oral residue after 3 ml and 5 ml liquid swallows. Voice changes after LSVT® included a significant increase in vocal intensity during sustained vowel phonation as well as during reading. Conclusions: LSVT® seemingly improved neuromuscular control of the entire upper aerodigestive tract, improving oral tongue and tongue base function during the oral and pharyngeal phases of swallowing as well as improving vocal intensity.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd</pub><pmid>11784821</pmid><doi>10.1136/jnnp.72.1.31</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-3050 |
| ispartof | Journal of neurology, neurosurgery and psychiatry, 2002-01, Vol.72 (1), p.31-36 |
| issn | 0022-3050 1468-330X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1737706 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Aged ASPB ASPD aspiration before the swallow aspiration during the swallow Barium Biological and medical sciences cricopharyngeal Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Deglutition - physiology dysphagia Female Follow-Up Studies Functional investigation of the digestive system fundamental frequency Humans Investigative techniques, diagnostic techniques (general aspects) Lee Silverman Voice Treatment Program LSVT Male MBS Medical sciences Middle Aged modified barium swallow Motility Neurology OPSE oral transit time ORES oropharyngeal swallow efficiency OTT Parkinson Disease - physiopathology Parkinson Disease - therapy Parkinson's disease Patients percentage of oral residue percentage of pharyngeal residue pharyngeal transit time Phonetics Pilot projects PRES PRT PTT Self evaluation sound pressure level Sound Spectrography Speech Therapy SPL Swallowing Treatment Outcome Video recorders Voice Disorders - physiopathology Voice Disorders - therapy Voice Quality - physiology Voice Training |
| title | Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): a pilot study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T07%3A12%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Swallowing%20and%20voice%20effects%20of%20Lee%20Silverman%20Voice%20Treatment%20(LSVT%C2%AE):%20a%20pilot%20study&rft.jtitle=Journal%20of%20neurology,%20neurosurgery%20and%20psychiatry&rft.au=El%20Sharkawi,%20A&rft.date=2002-01&rft.volume=72&rft.issue=1&rft.spage=31&rft.epage=36&rft.pages=31-36&rft.issn=0022-3050&rft.eissn=1468-330X&rft.coden=JNNPAU&rft_id=info:doi/10.1136/jnnp.72.1.31&rft_dat=%3Cproquest_pubme%3E71358045%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1781518939&rft_id=info:pmid/11784821&rfr_iscdi=true |